Analysis Of FinancialStatements Of Mergers And Acquisitions Enterprises In Dong Cheng Biochem Based On Investors' Perspective

Mergers and acquisitions is an important way for enterprises to achieve industrial change and upgrade.They can improve the concentration of industries and realize economies of scale while promoting the optimization of organizational structure and the rational allocation of resources.At present,M & A as a solid enterprise strategy and industrial optimization methods and measures,for China's economic development is playing an increasingly important role.Along with China's economic development,improving people's living standards,improve the health care system,as well as the aging of the population,the residents of the growing demand for health care and other factors,promote the development of China's medical and health industry.With the development of health industry,the pharmaceutical industry has attracted investors attention,all kinds of investors,whether institutional investors or individual investors,they in order to win a share in the rapid development of the capital market,mergers and acquisitions and give more attention to the concept of the concept of health industry.As investors,they are the basis of their investment decisions through value evaluation,while quantitative analysis based financial statement analysis is the first choice for investor valuation.Analysis of financial statements with specialization,generality and limitations,it does not fully reflect the financial situation of enterprises,in order to further understand the enterprise,must to the enterprise financial index and industry data were analyzed to find suitable investment targets and opportunities.This paper first through the PEST analysis of the merger of the status quo of China's pharmaceutical industry,then east medicine as the research object through case study method,according to the current situation of the research by the company,combined with the history of mergers and acquisitions of the company,to explore the effect of the 7 merger of the listed company 2008-2016 year before and after nearly 5 years of financial enterprises report.Using the financial analysis before and after the merger of East Pharmaceutical profitability,solvency,operational capacity,growth capacity and industry trend index of horizontal and vertical comparative analysis,thus obtains the financial change of the company after the merger.Through the financial index method to analyze the company's management strategy,merger process,problem solving and countermeasures,which contain important information in the financial statements to investors off,bring more persuasive investment basis,for investors at the same time,the development of the next few years provide the basis for decision making.Finally,through the study of the financial changes brought about by the M & A,we will make some investment proposals for investors in the pharmaceutical M & A investment.